A multi-country study of the economic burden of dengue fever: Vietnam, Thailand, and Colombia.

ABSTRACT:

Background

Dengue fever is a major public health concern in many parts of the tropics and subtropics. The first dengue vaccine has already been licensed in six countries. Given the growing interests in the effective use of the vaccine, it is critical to understand the economic burden of dengue fever to guide decision-makers in setting health policy priorities.

Methods/principal findings

A standardized cost-of-illness study was conducted in three dengue endemic countries: Vietnam, Thailand, and Colombia. In order to capture all costs during the entire period of illness, patients were tested with rapid diagnostic tests on the first day of their clinical visits, and multiple interviews were scheduled until the patients recovered from the current illness. Various cost items were

SUBMITTER: Lee JS 

PROVIDER: S-EPMC5679658 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature